Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 95

    1.

    Clinical significance of CD151 overexpression in subtypes of invasive breast cancer.

    Kwon MJ, Park S, Choi JY, Oh E, Kim YJ, Park YH, Cho EY, Kwon MJ, Nam SJ, Im YH, Shin YK, Choi YL.

    Br J Cancer. 2012 Feb 28;106(5):923-30. doi: 10.1038/bjc.2012.11. Epub 2012 Jan 31.

    PMID:
    22294188
    [PubMed - indexed for MEDLINE]
    2.

    Relationship between breast cancer risk factors and mammographic breast density in the Fernald Community Cohort.

    Yaghjyan L, Mahoney MC, Succop P, Wones R, Buckholz J, Pinney SM.

    Br J Cancer. 2012 Feb 28;106(5):996-1003. doi: 10.1038/bjc.2012.1. Epub 2012 Jan 26.

    PMID:
    22281662
    [PubMed - indexed for MEDLINE]
    3.

    Comparison of visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer.

    Mohammed ZM, McMillan DC, Elsberger B, Going JJ, Orange C, Mallon E, Doughty JC, Edwards J.

    Br J Cancer. 2012 Jan 17;106(2):383-8. doi: 10.1038/bjc.2011.569. Epub 2012 Jan 3.

    PMID:
    22251968
    [PubMed - indexed for MEDLINE]
    4.

    Phase I study of lapatinib plus vinorelbine in patients with locally advanced or metastatic breast cancer overexpressing HER2.

    Brain E, Isambert N, Dalenc F, Diéras V, Bonneterre J, Rezai K, Jimenez M, Mefti-Lacheraf F, Cottura E, Tresca P, Vanlemmens L, Mahier-Aït Oukhatar C, Lokiec F, Fumoleau P.

    Br J Cancer. 2012 Feb 14;106(4):673-7. doi: 10.1038/bjc.2011.591. Epub 2012 Jan 12.

    PMID:
    22240778
    [PubMed - indexed for MEDLINE]
    5.

    Brain metastases free survival differs between breast cancer subtypes.

    Berghoff A, Bago-Horvath Z, De Vries C, Dubsky P, Pluschnig U, Rudas M, Rottenfusser A, Knauer M, Eiter H, Fitzal F, Dieckmann K, Mader RM, Gnant M, Zielinski CC, Steger GG, Preusser M, Bartsch R.

    Br J Cancer. 2012 Jan 31;106(3):440-6. doi: 10.1038/bjc.2011.597. Epub 2012 Jan 10.

    PMID:
    22233926
    [PubMed - indexed for MEDLINE]
    6.

    Microcalcifications in breast cancer: novel insights into the molecular mechanism and functional consequence of mammary mineralisation.

    Cox RF, Hernandez-Santana A, Ramdass S, McMahon G, Harmey JH, Morgan MP.

    Br J Cancer. 2012 Jan 31;106(3):525-37. doi: 10.1038/bjc.2011.583. Epub 2012 Jan 10.

    PMID:
    22233923
    [PubMed - indexed for MEDLINE]
    7.

    Beyond trastuzumab: novel therapeutic strategies in HER2-positive metastatic breast cancer.

    Tsang RY, Finn RS.

    Br J Cancer. 2012 Jan 3;106(1):6-13. doi: 10.1038/bjc.2011.516. Review.

    PMID:
    22215104
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    8.

    Alcohol intake and mortality among women with invasive breast cancer.

    Harris HR, Bergkvist L, Wolk A.

    Br J Cancer. 2012 Jan 31;106(3):592-5. doi: 10.1038/bjc.2011.561. Epub 2012 Jan 3.

    PMID:
    22215064
    [PubMed - indexed for MEDLINE]
    9.

    Uptake of risk-reducing salpingo-oophorectomy in women carrying a BRCA1 or BRCA2 mutation: evidence for lower uptake in women affected by breast cancer and older women.

    Sidon L, Ingham S, Clancy T, Clayton R, Clarke A, Jones EA, Lalloo F, Evans DG.

    Br J Cancer. 2012 Feb 14;106(4):775-9. doi: 10.1038/bjc.2011.573. Epub 2011 Dec 20.

    PMID:
    22187038
    [PubMed - indexed for MEDLINE]
    10.

    Role of micronucleus test in predicting breast cancer susceptibility: a systematic review and meta-analysis.

    Cardinale F, Bruzzi P, Bolognesi C.

    Br J Cancer. 2012 Feb 14;106(4):780-90. doi: 10.1038/bjc.2011.567. Epub 2011 Dec 20. Review.

    PMID:
    22187037
    [PubMed - indexed for MEDLINE]
    11.

    High frequency of complex TP53 mutations in CNS metastases from breast cancer.

    Lo Nigro C, Vivenza D, Monteverde M, Lattanzio L, Gojis O, Garrone O, Comino A, Merlano M, Quinlan PR, Syed N, Purdie CA, Thompson A, Palmieri C, Crook T.

    Br J Cancer. 2012 Jan 17;106(2):397-404. doi: 10.1038/bjc.2011.464. Epub 2011 Dec 20.

    PMID:
    22187033
    [PubMed - indexed for MEDLINE]
    12.

    The presence of disseminated tumour cells in the bone marrow is inversely related to circulating free DNA in plasma in breast cancer dormancy.

    Payne RE, Hava NL, Page K, Blighe K, Ward B, Slade M, Brown J, Guttery DS, Zaidi SA, Stebbing J, Jacob J, Yagüe E, Shaw JA, Coombes RC.

    Br J Cancer. 2012 Jan 17;106(2):375-82. doi: 10.1038/bjc.2011.537. Epub 2011 Dec 13.

    PMID:
    22166803
    [PubMed - indexed for MEDLINE]
    13.

    Severe reaction to radiotherapy for breast cancer as the presenting feature of ataxia telangiectasia.

    Byrd PJ, Srinivasan V, Last JI, Smith A, Biggs P, Carney EF, Exley A, Abson C, Stewart GS, Izatt L, Taylor AM.

    Br J Cancer. 2012 Jan 17;106(2):262-8. doi: 10.1038/bjc.2011.534. Epub 2011 Dec 6.

    PMID:
    22146522
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    15. Cancers attributable to reproductive factors in the UK in 2010.

    Parkin DM.

    Br J Cancer. 2011 Dec 6;105 Suppl 2:S73-6. doi: 10.1038/bjc.2011.488. No abstract available.

    PMID:
    22158326
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    15.

    10. Cancers attributable to exposure to hormones in the UK in 2010.

    Parkin DM.

    Br J Cancer. 2011 Dec 6;105 Suppl 2:S42-8. doi: 10.1038/bjc.2011.483. No abstract available.

    PMID:
    22158320
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    16.

    9. Cancers attributable to inadequate physical exercise in the UK in 2010.

    Parkin DM.

    Br J Cancer. 2011 Dec 6;105 Suppl 2:S38-41. doi: 10.1038/bjc.2011.482. No abstract available.

    PMID:
    22158319
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    17.

    Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastases.

    Bartsch R, Berghoff A, Pluschnig U, Bago-Horvath Z, Dubsky P, Rottenfusser A, DeVries C, Rudas M, Fitzal F, Dieckmann K, Mader RM, Gnant M, Zielinski CC, Steger GG.

    Br J Cancer. 2012 Jan 3;106(1):25-31. doi: 10.1038/bjc.2011.531. Epub 2011 Nov 29.

    PMID:
    22127284
    [PubMed - indexed for MEDLINE]
    18.

    Exploring the use and impact of adjuvant trastuzumab for HER2-positive breast cancer patients in a large UK cancer network. Do the results of international clinical trials translate into a similar benefit for patients in South East Wales?

    Webster RM, Abraham J, Palaniappan N, Caley A, Jasani B, Barrett-Lee P.

    Br J Cancer. 2012 Jan 3;106(1):32-8. doi: 10.1038/bjc.2011.506. Epub 2011 Nov 22.

    PMID:
    22108523
    [PubMed - indexed for MEDLINE]
    19.

    Absence of the DNA repair enzyme human 8-oxoguanine glycosylase is associated with an aggressive breast cancer phenotype.

    Karihtala P, Kauppila S, Puistola U, Jukkola-Vuorinen A.

    Br J Cancer. 2012 Jan 17;106(2):344-7. doi: 10.1038/bjc.2011.518. Epub 2011 Nov 22.

    PMID:
    22108520
    [PubMed - indexed for MEDLINE]
    20.

    Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patients.

    Romano S, Fratini S, Ricevuto E, Procaccini V, Stifano G, Mancini M, Di Mauro M, Ficorella C, Penco M.

    Br J Cancer. 2011 Nov 22;105(11):1663-8. doi: 10.1038/bjc.2011.439. Epub 2011 Nov 8.

    PMID:
    22068815
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk